臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至:
或輸入年份:

從最近的開始

由舊到新排序

顯示項目 2234266-2234290 / 2346473 (共93859頁)
<< < 89366 89367 89368 89369 89370 89371 89372 89373 89374 89375 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-01T02:02:21Z	Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death	Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; Chang L.L.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:21Z	Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A0201 and HLA-A2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA Peptides	Liu K.-J.; Wang C.-C.; Chen L.-T.; ANN-LII CHENG; Lin D.-T.; Wu Y.-C.; Yu W.-L.; Hung Y.-M.; Yang H.-Y.; Juang S.-H.; Whang-Peng J.
臺大學術典藏	2021-09-01T02:02:22Z	Recent advances in therapy for gastric cancer	Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:22Z	Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy	Hsu C.-H.; Hsu H.-C.; Chen H.-L.; Gao M.; Yeh P.-Y.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:22Z	Low-dose thalidomide treatment for advanced hepatocellular carcinoma	Hsu C.; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; Lee P.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:22Z	Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells	Yeh K.-H.; ANN-LII CHENG; Wan J.-P.; Lin C.-S.; Liu C.-C.
臺大學術典藏	2021-09-01T02:02:22Z	High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma	Yeh K.-H.; Lu Y.-S.; Hsiao C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:23Z	Hepatitis B virus X protein activates a survival signaling by linking Src to phosphatidylinositol 3-kinase	Shih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG; Doong S.-L.
臺大學術典藏	2021-09-01T02:02:23Z	Survival-weighted health profile for long-term survivors of acute myelogenous leukemia	Hsu C.; Wang J.-D.; Hwang J.-S.; Tien H.-F.; Chang S.-M.; ANN-LII CHENG; Chen Y.-C.; Tang J.-L.
臺大學術典藏	2021-09-01T02:02:24Z	Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells	Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:24Z	Direct cardiac effects of As2O3 in rabbits: Evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration	Wu M.-H.; Lin C.-J.; Chen C.-L.; Su M.-J.; Sun S.S.-M.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:25Z	Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma	Hsu C.; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:25Z	Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age	Liang J.T.; Huang K.C.; ANN-LII CHENG; Jeng Y.M.; Wu M.S.; Wang S.M.
臺大學術典藏	2021-09-01T02:02:25Z	Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma	ANN-LII CHENG; Hsiung C.A.; Su I.-J.; Chen P.-J.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.
臺大學術典藏	2021-09-01T02:02:26Z	Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin	Hsu C.-H.; Hergenhahn M.; Chuang S.-E.; Yeh P.-Y.; Wu T.-C.; Gao M.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:26Z	Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy	Kuo S.-H.; Lin L.-I.; Chang C.-J.; Liu Y.-R.; Lin K.-S.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:26Z	A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil	Hsu C.-H.; ANN-LII CHENG; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H.
臺大學術典藏	2021-09-01T02:02:27Z	Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation	Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; Ea C.-K.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:27Z	The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells	Hergenhahn M.; Soto U.; Weninger A.; Polack A.; Hsu C.-H.; ANN-LII CHENG; R?sl F.
臺大學術典藏	2021-09-01T02:02:27Z	Basal levels and patterns of anticancer drug-induced activation of nuclear factor-κB (NF-κB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells	Chuang S.-E.; Yeh P.-Y.; Lu Y.-S.; Lai G.-M.; Liao C.-M.; Gao M.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:27Z	High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection	Liang J.-T.; Huang K.-C.; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Tang C.; Chang K.-J.
臺大學術典藏	2021-09-01T02:02:28Z	P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection	Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J.
臺大學術典藏	2021-09-01T02:02:28Z	HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity	Hsu C.; Huang C.-L.; Hsu H.-C.; Lee P.-H.; Wang S.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:28Z	Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer	Yang C.H.; Tsai C.M.; Wang L.S.; Lee Y.C.; Chang C.J.; Lui L.T.; Yen S.H.; Hsu C.; ANN-LII CHENG; Liu M.Y.; Chiang S.C.; Chen Y.M.; Luh K.T.; Huang M.H.; Yang P.-C.; Perng R.-P.
臺大學術典藏	2021-09-01T02:02:29Z	Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan.	Hsu C.H.; Chuang S.E.; Hergenhahn M.; Kuo M.L.; Lin J.K.; Hsieh C.Y.; ANN-LII CHENG

顯示項目 2234266-2234290 / 2346473 (共93859頁)
<< < 89366 89367 89368 89369 89370 89371 89372 89373 89374 89375 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2853537
	造訪人次 : 45265770 線上人數 : 820 教育部委託研究計畫計畫執行:國立臺灣大學圖書館